• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】24075

【品名】2-chloropyrazine

【CA登记号】14508-49-7

【 分 子 式 】C4H3ClN2

【 分 子 量 】114.534

【元素组成】C 41.95% H 2.64% Cl 30.95% N 24.46%

与该中间体有关的原料药合成路线共 8 条

合成路线1

该中间体在本合成路线中的序号:(I)

1) By condensation of 2 chloropyrazine (I) with N-acetylphenylhydroxylamine (II) by means of NaH in DMF (or NaOH in DMF - water; or with K2CO3 in acetone).

1 Coates, W.J. (SmithKline Beecham plc); 5-(4-Nitrophenyl)-2(1H)-pyrazinones. EP 0096517; US 4514568; US 4556711 .
2 Prous, J.; Castaner, J.; SK&F-94120. Drugs Fut 1986, 11, 2, 129.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(II) 24080 N-hydroxy-N-phenylacetamide C8H9NO2 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

2) The condensation of (I) with benzyl-N-hydroxy-N-phenylcarbamate (III) in ethanolic KOH gives 5-[4-(benzyloxycarbonylamino)phenyl]pyrazin-2(1H)-one (IV), which is hydrolyzed witn HBr in acetic acid yielding 5-(4-aminophenyl)pyrazin-2(1H)-one (V). Finally, this compound is acetylated with acetic anhydride.

1 Coates, W.J. (SmithKline Beecham plc); 5-(4-Nitrophenyl)-2(1H)-pyrazinones. EP 0096517; US 4514568; US 4556711 .
2 Prous, J.; Castaner, J.; SK&F-94120. Drugs Fut 1986, 11, 2, 129.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(III) 24076 heptyl hydroxy(phenyl)carbamate C14H21NO3 详情 详情
(IV) 24077 heptyl 4-(5-oxo-4,5-dihydro-2-pyrazinyl)phenylcarbamate C18H23N3O3 详情 详情
(V) 24078 4-(4,5-dihydro-2-pyrazinyl)aniline C10H11N3 详情 详情

合成路线3

该中间体在本合成路线中的序号:(II)

4-Amino-1-phenethylpiperidine (I) is stirred with chloropyrazine (II) and copper powder in phenyl ether at 170-175 C to obtain 1-phenethyl-4-[N-(pyrazinyl)amino]piperidine (III). Subsequent acylation of (III) with 2-furoyl chloride in 1,2-dichloroethane yields mirfentanil as the hydrochloride salt after cooling and filtration. Further purification is achieved by recrystallization from n-propanol.

1 Bagley, J.R.; Doorley, B.M.; Ossipov, M.H.; Knight, V.V.; Jerussi, T.P.; Benvenga, M.J.; Wilhelm, J.A.; Waters, S.J.; Spaulding, T.C.; Wynn, R.L.; Rudo, F.G.; Glass, P.S.A.; MIRFENTANIL HYDROCHLORIDE. Drugs Fut 1990, 15, 8, 798.
2 Bagley, J.R.; Wynn, R.L.; Rudo, F.G.; Doorley, B.M.; Spender, H.K.; Spaulding, T.; New 4-(heteroanilido)-piperidines structurally related to the pure opioid agonist, fentanyl, with agonist and/or antagonist properties. J Med Chem 1989, 32, 3, 663-671.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
26093 2-Furoyl chloride 527-69-5 C5H3ClO2 详情 详情
(I) 31167 1-phenethyl-4-piperidinylamine; 1-phenethyl-4-piperidinamine; N-(Phenethyl)-4-aminopiperidine 51448-56-7 C13H20N2 详情 详情
(II) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(III) 31168 N-(1-phenethyl-4-piperidinyl)-N-(2-pyrazinyl)amine; N-(1-phenethyl-4-piperidinyl)-2-pyrazinamine C17H22N4 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Reaction of 2-chloropyrazine (I) with 3,4-dichlorophenylmagnesium bromide (II) in the presence of [1,2-bis(diphenylphosphino)ethane]nickel(II) chloride produced the 2-arylpyrazine (III), which was reduced to the corresponding piperazine (IV) by means of DIBAL in THF. In a different procedure, bromination of methyl 3,4-dichlorophenylacetate (V) using N-bromosuccinimide, followed by reaction of the resulting bromo ester (VI) with ethylenediamine (VII) afforded the piperazinone (VIII), which was further reduced to (IV) by using LiAlH4 in Et2O.

1 Anthes, J.C.; McPhail, A.T.; Blythin, D.J.; Shue, H.-J.; Chen, X.; Piwinski, J.J.; shih, N.-Y.; Discovery of Sch 62373 and analogs, of novel series of 2-phenylpiperazines exhibiting potent dual NK1/NK2 antagonist activity. 221st ACS Natl Meet (April 1 2001, San Diego) 2001, Abst MEDI 244.
2 Shue, H.-J.; Shih, N.-Y.; Blythin, D.J.; Chen, X.; Tom, W.C.; Piwinski, J.J.; McCormick, K.D. (Schering Corp.); Piperazino derivs. as neurokinin antagonists. EP 0823906; US 5719156; WO 9634864 .
3 Piwinski, J.J.; McCormick, K.D.; Shue, H.-J.; Chen, X.; Shih, N.-Y.; Blythin, D.J. (Schering Corp.); Piperazino derivs. as neurokinin antagonists. EP 0850236; JP 2000344766; US 5795894; US 5892039; WO 9708166 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(II) 10069 Bromo(3,4-dichlorophenyl)magnesium 79175-35-2 C6H3BrCl2Mg 详情 详情
(III) 47945 2-(3,4-dichlorophenyl)pyrazine C10H6Cl2N2 详情 详情
(IV) 47946 2-(3,4-dichlorophenyl)piperazine C10H12Cl2N2 详情 详情
(V) 47947 methyl 2-(3,4-dichlorophenyl)acetate C9H8Cl2O2 详情 详情
(VI) 47948 methyl 2-bromo-2-(3,4-dichlorophenyl)acetate C9H7BrCl2O2 详情 详情
(VII) 14754 ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine 107-15-3 C2H8N2 详情 详情
(VIII) 47949 3-(3,4-dichlorophenyl)-2-piperazinone C10H10Cl2N2O 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

 

1 Hansen KB, Balsells J. Dreher S et a1. 2005. First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin. Org Proc Rea.Dev.,9(5): 634~639.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(II) 66713 2-Hydrazinopyrazine 54608-52-5 C4H6N4 详情 详情
(III) 66714     C8H4F6N4O2 详情 详情
(IV) 66715 3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine   C6H3F3N4 详情 详情
(V) 66705 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride 486460-21-3 C6H7F3N4.HCl 详情 详情
(VI) 66716 methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate 769195-26-8 C11H9F3O3 详情 详情
(VII) 66717 (R)-3-hydroxy-4-(2,4,5-trifluorophenyl)butanoic acid   C10H9F3O3 详情 详情
(VIII) 66718 (R)-N-(benzyloxy)-3-hydroxy-4-(2,4,5-trifluorophenyl)butanamide   C17H16F3NO3 详情 详情
(IX) 66719 (R)-1-(benzyloxy)-4-(2,4,5-trifluorobenzyl)azetidin-2-one   C17H14F3NO2 详情 详情
(X) 66720 (R)-3-((benzyloxy)amino)-4-(2,4,5-trifluorophenyl)butanoic acid   C17H16F3NO3 详情 详情
(XI) 66721 (R)-3-((benzyloxy)amino)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one   C23H21F6N5O2 详情 详情
(XII) 66722 (R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one 486460-32-6 C16H15F6N5O 详情 详情

合成路线6

该中间体在本合成路线中的序号:(IX)

 

1 Kim D, Wang LP, Becoru M, et al. 2005. (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl}l-(2,4,5-trifluorophenyl)butan-2-amine:a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. J Med Chem, 48(1):141~151
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(II) 66723 1-(bromomethyl)-2,4,5-trifluorobenzene   C7H4BrF3 详情 详情
(I) 10296 (R)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine; (3R)-3-Isopropyl-5-methoxy-3,6-dihydro-2-pyrazinyl methyl ether; (2R)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine 109838-85-9 C9H16N2O2 详情 详情
(III) 66724 (2S,5R)-2-isopropyl-3,6-dimethoxy-5-(2,4,5-trifluorobenzyl)-2,5-dihydropyrazine   C16H19F3N2O2 详情 详情
(IV) 66725 (R)-methyl 2-amino-3-(2,4,5-trifluorophenyl)propanoate   C10H10F3NO2 详情 详情
(V) 66729 (R)-methyl 2-((tert-butoxycarbonyl)amino)-3-(2,4,5-trifluorophenyl)propanoate   C15H18F3NO4 详情 详情
(VI) 66728 (R)-2-((tert-butoxycarbonyl)amino)-3-(2,4,5-trifluorophenyl)propanoic acid   C14H16F3NO4 详情 详情
(VII) 66727 (R)-tert-butyl (4-diazo-3-oxo-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate   C15H16F3N3O3 详情 详情
(VIII) 66726 (R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid   C15H18F3NO4 详情 详情
(IX) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(X) 66713 2-Hydrazinopyrazine 54608-52-5 C4H6N4 详情 详情
(XI) 66730 2,2,2-trifluoro-N'-(pyrazin-2-yl)acetohydrazide 2,2,2-trifluoroacetate   C6H5F3N4O.C2HF3O2 详情 详情
(XII) 66715 3-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine   C6H3F3N4 详情 详情
(XIII) 66731 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine   C6H7F3N4 详情 详情
(XIV) 66732 (R)-tert-butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate   C21H23F6N5O3 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XVIII)

Reduction of methyl 4-formyl-3-nitrobenzoate (XIII) by means of Fe and HCl in EtOH, followed by Friedländer condensation of the resulting aminoaldehyde with acetophenone (XIV) in the presence of KOH at 95 °C, and treatment with HCl, yields 2-phenylquinoline-7-carboxylic acid hydrochloride (XV). Reduction of acid (XV) with LiAlH4 in THF gives alcohol (XVI), which is then oxidized by means of MnO2 in CHCl3 to give 2-phenylquinoline-7-carbaldehyde (XVII). Coupling of carbaldehyde (XVII) with the metalated derivative of 2-chloropyrazine (XVIII) in the presence LTMP (prepared from BuLi and TMP) in THF yields the diaryl carbinol (XIX), which is then subjected to Mitsunobu reaction with phthalimide (XX) in the presence of PS-PPh3 and DIAD in THF to provide the N-substituted phthalimide (XXI). Hydrazinolysis of phthalimide (XXI) with NH2NH2 in EtOH/CH2Cl2 then affords amine (I).
Alternatively, carbaldehyde (XVII) can be prepared by arylation of 7-methylquinoline (XXII) with phenyl lithium in THF, followed by air oxidation to produce 7-methyl-2-phenylquinoline (XXIII). Side chain oxidation of (XXIII) using SeO2 at 160 °C provides the target aldehyde (XVII) .

1 Arnold, L.D., Cesario, C., Coate, H. et al. (OSI Pharmaceuticals, Inc.). 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors. EP 1740591, EP 2168968, EP 2305682, EP 2308879, JP 2007531754, JP 2009197013, US 200635031, WO 005097800.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 68918 (3-chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methanamine   C20H15ClN4 详情 详情
(XIII) 68930 methyl 4-formyl-3-nitrobenzoate;4-Formyl-3-nitrobenzoicacid methyl ester 153813-69-5 C9H7NO5 详情 详情
(XIV) 10317 Acetophenone 98-86-2 C8H8O 详情 详情
(XV) 68931 2-phenylquinoline-7-carboxylic acid hydrochloride   C16H11NO2.HCl 详情 详情
(XVI) 68932 (2-phenylquinolin-7-yl)methanol   C16H13NO 详情 详情
(XVII) 68933 2-phenylquinoline-7-carbaldehyde   C16H11NO 详情 详情
(XVIII) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(XIX) 68934 (3-chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methanol   C20H14ClN3O 详情 详情
(XX) 12376 Phthalimide; 1H-Isoindole-1,3(2H)-dione; Isoindole-1,3-dione;Phthalic dicarboximide;Phenylimide;Isoindole-1,3-dione 85-41-6 C8H5NO2 详情 详情
(XXI) 68935 2-((3-chloropyrazin-2-yl)(2-phenylquinolin-7-yl)methyl)isoindoline-1,3-dione   C28H17ClN4O2 详情 详情
(XXII) 68936 7-methylquinoline;m-Toluquinoline 612-60-2 C10H9N 详情 详情
(XXIII) 68937 7-methyl-2-phenylquinoline 27356-39-4 C16H13N 详情 详情

合成路线8

该中间体在本合成路线中的序号:(XVIII)

Metalation of 2-chloropyrazine (XVIII) with LTMP (prepared from BuLi and TMP) in THF, followed by formylation with DMF and subsequent reduction with NaBH4 yields (3-chloro-2-pyrazinyl)methanol (XXXI). Mitsunobu coupling of alcohol (XXXI) with phthalimide (XX) in the presence of PPh3 and DIAD in THF gives the N-substituted phthalimide (XXXII), which is then subjected to hydrazinolysis with NH2NH2 in CH2Cl2 to provide, after treatment with HCl, (3-chloro-2-pyrazinyl)methylamine dihydrochloride (XXXIII) . Coupling of amine (XXXIII) with succinimidyl ester (XXXIV) (prepared by condensation of 3-oxocyclobutanecarboxylic acid [XXXVI] with N-hydroxysuccinimide [XXXV] using DCC in isopropyl acetate [3]) in the presence of NaHCO3 in THF/H2O produces the 3-oxocyclobutanecarboxamide (XXXVII). Cyclization of amide (XXXVII) in the presence POCl3 and DMF in EtOAc affords 3-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclobutanone (XXXVIII), which is then brominated by means of NBS in DMF to yield the 1-bromo derivative (XXXIX) . Addition of CH3MgI to ketone (XXXIX) in THF, followed by chloride substitution with NH3, gives rise to cis-3-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol (XII) .

1 Arnold, L.D., Cesario, C., Coate, H. et al. (OSI Pharmaceuticals, Inc.). 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors. EP 1740591, EP 2168968, EP 2305682, EP 2308879, JP 2007531754, JP 2009197013, US 200635031, WO 005097800.
2 Mulvihill, K.M., Castelhano, A.L. (OSI Pharmaceuticals, Inc.). Process to prepare substituted imidazopyrazine compounds. US 2007129547, WO 2007067709
3 Volk, B., Buck, E., Coate, H. et al. OSI-906: A novel, potent, and selective first-in-class small molecule insulin-like growth factor 1 receptor (IGF-1R) inhibitor in phase I clinical trials. 238th ACS Natl Meet (Aug 16-20, Washington) 2009, Abst MEDI 152.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XII) 68929     C11H13BrN4O 详情 详情
(XVIII) 24075 2-chloropyrazine 14508-49-7 C4H3ClN2 详情 详情
(XX) 12376 Phthalimide; 1H-Isoindole-1,3(2H)-dione; Isoindole-1,3-dione;Phthalic dicarboximide;Phenylimide;Isoindole-1,3-dione 85-41-6 C8H5NO2 详情 详情
(XXXI) 68943 (3-chloropyrazin-2-yl)methanol;3-chloro-Pyrazinemethanol;3-chloro-2-Pyrazinemethano 89283-32-9 C5H5ClN2O 详情 详情
(XXXII) 68944 2-((3-chloropyrazin-2-yl)methyl)isoindoline-1,3-dione   C13H8ClN3O2 详情 详情
(XXXIII) 68945 (3-chloropyrazin-2-yl)methanamine dihydrochloride   C5H6ClN3.2HCl 详情 详情
(XXXIV) 68946 2,5-dioxopyrrolidin-1-yl 3-oxocyclobutanecarboxylate   C9H9NO5 详情 详情
(XXXV) 10264 1-Hydroxydihydro-1H-pyrrole-2,5-dione; N-Hydroxysuccinimide; 1-Hydroxy-2,5-pyrrolidinedione 6066-82-6 C4H5NO3 详情 详情
(XXXVI) 68947 3-oxocyclobutanecarboxylic acid;(3-Oxocyclobutyl)carboxylic acid 23761-23-1 C5H6O3 详情 详情
(XXXVII) 68948 N-((3-chloropyrazin-2-yl)methyl)-3-oxocyclobutanecarboxamide   C10H10ClN3O2 详情 详情
(XXXVIII) 68949 3-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclobutanone   C10H8ClN3O 详情 详情
(XXXIX) 68950 3-(1-bromo-8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclobutanone   C10H7BrClN3O 详情 详情
Extended Information